TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9694404

Group type: EXPERIMENTAL
Intervention: 5 mg oral melatonin administered at 12.30 hr
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study: 7861681

Group type: EXPERIMENTAL
Intervention: Finger-drawing for encoding
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Finger-drawing for searching
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Finger-drawing for both encoding and searching
Number of subjects: 40

Group type: COMPARATOR
Intervention: Imagery encoding
Number of subjects: 40

Group type: COMPARATOR
Intervention: Verbal encoding
Number of subjects: 40
Study: 2768537

Group type: EXPERIMENTAL
Intervention: Manual tooth-brushing
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Power toothbrushing
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Manual toothbrushing plus irrigation
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Power toothbrushing plus irrigation
Number of subjects: 108
Study: 29210957

Group type: EXPERIMENTAL
Intervention: Caffeine gum (CAF) 400 mg; 4.1 ± 0.5 mg·kg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo gum (PLC)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine gum (CAF)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cognitive performance (reaction time and Stroop test)
Number of subjects: 14
Study: 31730630

Group type: EXPERIMENTAL
Intervention: MCH-ART intervention (integrated maternal/pediatric care)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MCH-ART intervention
Number of subjects: 0
Study: 29069628

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 92
Study: 26124486

Group type: EXPERIMENTAL
Intervention: Pemetrexed/Cisplatin
Number of subjects: 321

Group type: COMPARATOR
Intervention: Gemcitabine/Cisplatin
Number of subjects: 321
Study: 23693129

Group type: EXPERIMENTAL
Intervention: Body acupuncture; Sa-am acupuncture
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 21045662

Group type: EXPERIMENTAL
Intervention: Corneal collagen cross-linking (CXL) by riboflavin/UV light
Number of subjects: 10
Study: 19114204

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20 mg/d)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 17006067

Group type: EXPERIMENTAL
Intervention: Combitube (ETC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 120
Study: 12732501

Group type: EXPERIMENTAL
Intervention: Unrelated donor stem cell transplantation (UD‐SCT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 81
Study: 10971307

Group type: EXPERIMENTAL
Intervention: Asimadoline 5 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Asimadoline 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8855175

Group type: EXPERIMENTAL
Intervention: T-alpha1 900 microg/m2 body surface area twice weekly for 6 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Interferon alfa (IFN-alpha) 5 MU three times weekly for 6 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Interferon alfa (IFN-alpha)
Number of subjects: 33
Study: 1629477

Group type: EXPERIMENTAL
Intervention: Simultaneous presentation of stimuli (profile analysis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Successive presentation of stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simultaneous presentation of tonal complexes (10 to 11 components)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Successive presentation of tonal complexes (10 to 11 components)
Number of subjects: 0
Study: 6812685

Group type: EXPERIMENTAL
Intervention: Aspirin 40 mg every 48 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin 40 mg every 72 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both regimens of aspirin
Number of subjects: 0
Study: 31116392

Group type: EXPERIMENTAL
Intervention: Online professional development program for preschool teachers
Number of subjects: 818

Group type: COMPARATOR
Intervention: In-person delivery of professional development to preschool teachers (Phase I)
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Online delivery of professional development to preschool teachers (Phase II)
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Statewide dissemination of SHAPES (Phase III)
Number of subjects: 818
Study: 28237867

Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study: 26233808

Group type: EXPERIMENTAL
Intervention: NABOTA
Number of subjects: 197

Group type: COMPARATOR
Intervention: Botox
Number of subjects: 197
Study: 23707410

Group type: EXPERIMENTAL
Intervention: 22-degree bent tip (Group 1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 12-degree bent tip (Group 2)
Number of subjects: 90
Study: 21550310

Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate (500 mg/day for 1 week, then once a week to complete 12 weeks)
Number of subjects: 1516

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1516

Group type: EXPERIMENTAL
Intervention: Chloroquine phosphate
Number of subjects: 1516
Study: 19506780

Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment (MBT)
Number of subjects: 0
Study: 17560728

Group type: EXPERIMENTAL
Intervention: Psychological stress challenge (Trier Social Stress Test - TSST)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Healthy normal weight subjects
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Patients with BED
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cortisol responders
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Change in ghrelin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Higher quartile of ghrelin response
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Eating related scores
Number of subjects: 24
Study: 15224627

Group type: EXPERIMENTAL
Intervention: Heart sounds feedback via headphones
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Heart sounds feedback via loudspeakers audible to observers
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 64
Study: 12562140

Group type: EXPERIMENTAL
Intervention: Substance P receptor antagonists (SPAs) aprepitant (MK‐0869) and compound A
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 0
Study: 10194615

Group type: EXPERIMENTAL
Intervention: Randomised Controlled Trials (RCTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Informed Consent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RCTs
Number of subjects: 0
Study: 7661204

Group type: EXPERIMENTAL
Intervention: Amsler grid testing
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tangent screen
Number of subjects: 15
Study: 2568350

Group type: EXPERIMENTAL
Intervention: Chlordesmethyldiazepam (long-acting benzodiazepine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lorazepam (short-acting benzodiazepine)
Number of subjects: 0
Study: 68228

Group type: EXPERIMENTAL
Intervention: intermittent constant‐dosage heparin
Number of subjects: 76

Group type: COMPARATOR
Intervention: continuously infused heparin with laboratory control
Number of subjects: 76

Group type: COMPARATOR
Intervention: surgical wounds
Number of subjects: 76

Group type: COMPARATOR
Intervention: arterial and venous puncture sites
Number of subjects: 76
Study: 30496510

Group type: EXPERIMENTAL
Intervention: Pulsed Ultrasound (PUS) treatment
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (PUS procedure without emission)
Number of subjects: 47
Study: 27918196

Group type: EXPERIMENTAL
Intervention: Oral riboflavin incorporated into active treatment pills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active study ingredients daidzein and genistein
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo pills
Number of subjects: 0
Study: 25548329

Group type: EXPERIMENTAL
Intervention: Educational text message reminders
Number of subjects: 660

Group type: COMPARATOR
Intervention: Conventional text message reminders
Number of subjects: 660

Group type: COMPARATOR
Intervention: Written reminder-only
Number of subjects: 660
Study: 23208525

Group type: EXPERIMENTAL
Intervention: High dose intravenous vitamin C (HDVC) 200 mg/kg/day for 10 days plus oral vitamin C 2000 mg for 30 days after discharge
Number of subjects: 72

Group type: COMPARATOR
Intervention: Systemic steroid treatment for 15 days
Number of subjects: 72
Study: 22234000

Group type: EXPERIMENTAL
Intervention: parecoxib 40 mg IV
Number of subjects: 338

Group type: COMPARATOR
Intervention: ketoprofen 100 mg IV
Number of subjects: 338
Study: 19238488

Group type: EXPERIMENTAL
Intervention: Varenicline with behavioral smoking cessation treatment
Number of subjects: 1117
Study: 17445101

Group type: EXPERIMENTAL
Intervention: Early Treatment (ET) with almotriptan 12.5 mg, treated at earliest onset of headache pain (within 1 hour)
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Standard Treatment (ST) with almotriptan 12.5 mg, treated when headache pain intensity is moderate or severe
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Early Treatment (ET) subgroup treating headache pain within 1 hour of onset
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Standard Treatment (ST) subgroups treating within 1 hour versus greater than 1 hour after headache onset
Number of subjects: 1450

Group type: EXPERIMENTAL
Intervention: Adverse events in Early Treatment (ET) group
Number of subjects: 1450

Group type: COMPARATOR
Intervention: Adverse events in Standard Treatment (ST) group
Number of subjects: 1450
Study: 15329068

Group type: COMPARATOR
Intervention: Valproic acid (VPA)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Lamotrigine (LTG)
Number of subjects: 38
Study: 12566649

Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCI (balloon)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCI (stent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 0
Study: 11229251

Group type: EXPERIMENTAL
Intervention: Critical CPAP (Group A)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Subcritical CPAP (Group B)
Number of subjects: 28
Study: 8087439

Group type: EXPERIMENTAL
Intervention: Lung Cancer Symptom Scale (LCSS) administered at baseline, day 29, and day 71
Number of subjects: 144
Study: 2767747

Group type: EXPERIMENTAL
Intervention: Intrathecal pentazocine (0, 1, 2, 3, 4, and 5 mg) along with 1% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal pentazocine (3 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal pentazocine (higher doses)
Number of subjects: 60
Study: 271411

Group type: EXPERIMENTAL
Intervention: Iris-clip lens implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple cataract extraction
Number of subjects: 0
Study: 30996338

Group type: EXPERIMENTAL
Intervention: Visual search training (minimum 30 min, 5 days/week over 6 weeks)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Fresnel prisms (minimum 2 hours, 5 days/week over 6 weeks)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard care - information only
Number of subjects: 87
Study: 30080227

Group type: EXPERIMENTAL
Intervention: Exercise intervention (n=44), 60 minutes/session, twice per week for 24 weeks
Number of subjects: 91

Group type: COMPARATOR
Intervention: Social-based activities (n=47), 60 minutes/session, twice per week for 24 weeks
Number of subjects: 91
Study: 26210894

Group type: EXPERIMENTAL
Intervention: 1-3 years of maintenance Bacillus Calmette-Guérin (BCG) after transurethral resection of the bladder (TURB) and induction BCG
Number of subjects: 1812

Group type: EXPERIMENTAL
Intervention: 1-3 years of maintenance Bacillus Calmette-Guérin (BCG)
Number of subjects: 1812
Study: 24096920

Group type: EXPERIMENTAL
Intervention: Simulation exercises followed by didactic lecture
Number of subjects: 29

Group type: COMPARATOR
Intervention: Simulation after lecture
Number of subjects: 29
Study: 21645945

Group type: EXPERIMENTAL
Intervention: Training session for physicians (Group 1)
Number of subjects: 4076

Group type: COMPARATOR
Intervention: No training session for physicians (Group 2)
Number of subjects: 4076

Group type: EXPERIMENTAL
Intervention: Combined population (Groups 1 + 2)
Number of subjects: 4076
Study: 20442758

Group type: EXPERIMENTAL
Intervention: 5 days on/2 days off treatment
Number of subjects: 146

Group type: COMPARATOR
Intervention: Continuous treatment
Number of subjects: 146
Study: 17363764

Group type: EXPERIMENTAL
Intervention: Message from a low credibility source before the target message
Number of subjects: 0

Group type: COMPARATOR
Intervention: Message from a high credibility source before the target message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Priming with a dissimilarity mindset before the target message
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Priming with a similarity mindset before the target message
Number of subjects: 0
Study: 15786795

Group type: EXPERIMENTAL
Intervention: Psycho-educational intervention (educational brochure + motivational interview)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 12034036

Group type: EXPERIMENTAL
Intervention: Low-dose interferon-alpha2b (1 million IU) with didanosine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intermediate-dose interferon-alpha2b (10 million IU) with didanosine
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Intermediate-dose interferon-alpha2b
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low-dose and intermediate-dose interferon-alpha2b
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Baseline CD4 count
Number of subjects: 68
Study: 10024260

Group type: EXPERIMENTAL
Intervention: Feedback intervention (graphical displays of prescribing rates and educational newsletters)
Number of subjects: 2440

Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 2440
Study: 8584481

Group type: EXPERIMENTAL
Intervention: Zalcitabine with food
Number of subjects: 20

Group type: COMPARATOR
Intervention: Zalcitabine without food (fasting)
Number of subjects: 20
Study: 1973352

Group type: EXPERIMENTAL
Intervention: H0 model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empirical data
Number of subjects: 0
Study: 406875

Group type: EXPERIMENTAL
Intervention: Hydergine (ergot derivative)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31340089

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 28911749

Group type: EXPERIMENTAL
Intervention: Participatory women's groups and counselling through home visits
Number of subjects: 3001

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3001
Study: 25305572

Group type: EXPERIMENTAL
Intervention: V mode electrothermal energy
Number of subjects: 101

Group type: COMPARATOR
Intervention: cut/coag electrothermal energy
Number of subjects: 101
Study: 23473369

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 11145

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 11145
Study: 21600563

Group type: EXPERIMENTAL
Intervention: Exposure and Ritual Prevention (EX/RP) treatment for OCD, 17 sessions over 8 weeks
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: OCPD diagnosis
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Perfectionism (OCPD criterion)
Number of subjects: 49
Study: 19694112

Group type: EXPERIMENTAL
Intervention: IVR (Interactive Voice Response) technology, 11 automated calls over 6 months
Number of subjects: 331

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: IVR (Interactive Voice Response) technology
Number of subjects: 331
Study: 16467232

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (40% of participants, n = 19,541)
Number of subjects: 48835

Group type: COMPARATOR
Intervention: Comparison group (60% of participants, n = 29,294)
Number of subjects: 48835

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (adherent women)
Number of subjects: 48835

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (high-fat diet at baseline)
Number of subjects: 48835

Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (tumor hormone receptor characteristics)
Number of subjects: 48835
Study: 15271196

Group type: EXPERIMENTAL
Intervention: Ciclopirox shampoo 1%
Number of subjects: 499

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 499
Study: 11005044

Group type: EXPERIMENTAL
Intervention: Effective forms of ECT
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: High dosage right unilateral ECT
Number of subjects: 57

Group type: COMPARATOR
Intervention: Low dosage right unilateral ECT
Number of subjects: 57

Group type: COMPARATOR
Intervention: Generalized seizure expression
Number of subjects: 57
Study: 9217347

Group type: EXPERIMENTAL
Intervention: Enhancing Self‐Concept workshop
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (information sessions)
Number of subjects: 74
Study: 7923712

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 51
Study: 3528889

Group type: EXPERIMENTAL
Intervention: Piracetam (2.4 to 9.9 g/day)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Piracetam combined with phosphatidylcholine (PC) (18 g/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Phosphatidylcholine (PC) alone
Number of subjects: 18
Study: 29986761

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET) group with HRmax > 60%
Number of subjects: 198

Group type: COMPARATOR
Intervention: Alternative Intervention (AI) group with low-level exercises
Number of subjects: 198

Group type: COMPARATOR
Intervention: Waiting-list Control (WC) group
Number of subjects: 198
Study: 28052887

Group type: EXPERIMENTAL
Intervention: Pasteurized human milk (PHM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Raw human milk (RHM)
Number of subjects: 12
Study: 26258597

Group type: EXPERIMENTAL
Intervention: Low volume high intensity interval training (HIIT) on cycle ergometer, 3 times a week for 8 weeks (10×60 sec. HIIT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 10
Study: 24194899

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (liquid bleach) for household water treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: No water treatment (Control)
Number of subjects: 36
Study: 21918237

Group type: EXPERIMENTAL
Intervention: 12-week exercise intervention arm (n = 58)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Health and wellness control arm (n = 52)
Number of subjects: 110
Study: 18438572

Group type: EXPERIMENTAL
Intervention: Laparoscopic retroperitoneal lumbar sympathectomy (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No surgical intervention (Group B - control)
Number of subjects: 30
Study: 16612489

Group type: EXPERIMENTAL
Intervention: Psychodramatic psychotherapy (4 individual and 24 structured group sessions)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no psychodramatic psychotherapy)
Number of subjects: 20
Study: 14962145

Group type: EXPERIMENTAL
Intervention: Multidisciplinary fall-prevention program (experimental ward)
Number of subjects: 825

Group type: COMPARATOR
Intervention: Current practice (control wards)
Number of subjects: 825
Study: 10930900

Group type: EXPERIMENTAL
Intervention: Omeprazole MUPS 20 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 16
Study: 9200342

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 120
Study: 8408666

Group type: EXPERIMENTAL
Intervention: Parent ratings of nausea and emesis
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Child's anxiety and antiemetic regimen
Number of subjects: 33
Study: 3542451

Group type: EXPERIMENTAL
Intervention: Intraperitoneal insulin above transverse mesocolon (0.2 IU/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intraperitoneal insulin below transverse mesocolon (0.2 IU/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intramuscular insulin (0.2 IU/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Subcutaneous insulin (0.2 IU/kg)
Number of subjects: 14
Study: 30300037

Group type: EXPERIMENTAL
Intervention: Natural altitude training (NAT)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Simulated live high:train low (SIM)
Number of subjects: 22
Study: 30230666

Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM) + usual care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 0
Study: 26540248

Group type: EXPERIMENTAL
Intervention: Home care intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community care intervention
Number of subjects: 0
Study: 25364946

Group type: EXPERIMENTAL
Intervention: Hatha yoga therapy (weekly 1-hour sessions for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (regular treatment including daycare rehabilitation program)
Number of subjects: 50
Study: 22892463

Group type: EXPERIMENTAL
Intervention: Annual application of silver diamine fluoride (SDF)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Semi-annual application of silver diamine fluoride (SDF)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Annual application of high fluoride-releasing glass ionomer
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 212
Study: 20645484

Group type: EXPERIMENTAL
Intervention: Spinal-epidural anesthesia and analgesia
Number of subjects: 45

Group type: COMPARATOR
Intervention: Spinal-intravenous anesthesia and analgesia
Number of subjects: 45

Group type: COMPARATOR
Intervention: General-intravenous anesthesia and analgesia
Number of subjects: 45
Study: 18853995

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Proton-pump inhibitor (PPI) treatment for 8 weeks
Number of subjects: 29
Study: 16027336

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 70

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 70
Study: 12647454

Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0